H. Kim Lyerly

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

Michael A. Morse, Jennifer Garst, Takuya Osada et al. · Journal of Translational Medicine · 2005 · 1.1K citations · Full text

Identification of the Envelope V3 Loop as the Primary Determinant of Cell Tropism in HIV-1

Stephen S. Hwang, Terence J. Boyle, H. Kim Lyerly et al. · Science · 1991 · 864 citations

ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

Robert Yarchoan, KentJ. Weinhold, H. Kim Lyerly et al. · The Lancet · 1986 · 803 citations

Htlv-iii/lav Replication, Human Retrovirus, An Inhibitor +10

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

Smita K. Nair, David Boczkowski, Michael Morse et al. · Nature Biotechnology · 1998 · 398 citations

Human Dendritic Cells, Immunology, Primary Carcinoembryonic Antigen +10

Migration of human dendritic cells after injection in patients with metastatic malignancies.

Michael A. Morse, Rob Coleman, Gamal Akabani et al. · PubMed · 1999 · 354 citations

Cell Therapy, Active Immunotherapy, Immunology +16